Íåâðîòè÷åñêèå, ñâÿçàííûå ñî ñòðåññîì è ñîìàòîôîðìíûå ðàññòðîéñòâà (F40-F48)
Ôîáè÷åñêèå òðåâîæíûå ðàññòðîéñòâà
ÀÍÀÔÐÀÍÈËNOVARTIS PHARMA AG
ÀÒÀÐÀÊÑ®UCB S.A. PHARMA SECTOR
ÃÐÀÍÄÀÊÑÈÍEGIS PHARMACEUTICALS Ltd.
ÇÎËÎÔÒ™PFIZER
ËÎÐÀÔÅÍTARCHOMIN PHARMACEUTICAL WORKS POLFA S.A.
ÍÅÃÐÓÑÒÈÍ®HEXAL AG
ÍÎÂÎ-ÏÀÑÑÈÒ®IVAX-CR a.s.
ÏÀÊÑÈËSmithKline Beecham Pharmaceuticals
ÏÈÐÀÇÈÄÎË®ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ
ÐÅÊÑÅÒÈÍGEDEON RICHTER Ltd.
ÐÅËÀÍÈÓÌWARSAW PHARMACEUTICAL WORK POLFA
ÑÅÄÓÊÑÅÍÃÅÄÅÎÍ ÐÈÕÒÅÐ-ÐÓÑ ÇÀÎ
ÑÅÄÓÊÑÅÍGEDEON RICHTER Ltd.
ÒÈÇÅÐÖÈÍEGIS PHARMACEUTICALS Ltd.
ÒÈÑÎÍÂÅÐÎÔÀÐÌ ÇÀÎ
ÔËÞÀÍÊÑÎËH.LUNDBECK A/S